Immunohistochemical expression of excision repair cross-complementing 1 (ERCC1) in non-small-cell lung cancer: implications for patient outcome

ÇUBUKÇU E., Olmez O. F., SARAYDAROĞLU Ö., Akcali U., Kanat O., Kurt E., ...Daha Fazla

CLINICAL & TRANSLATIONAL ONCOLOGY, cilt.13, sa.11, ss.826-830, 2011 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 13 Sayı: 11
  • Basım Tarihi: 2011
  • Doi Numarası: 10.1007/s12094-011-0741-7
  • Dergi Adı: CLINICAL & TRANSLATIONAL ONCOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.826-830
  • Anahtar Kelimeler: Non-small-cell lung cancer, Excision repair cross-complementing 1, Immunohistochemistry, Prognosis, DNA-REPAIR, MESSENGER-RNA, CHEMOTHERAPY, BIOMARKERS, RESISTANCE, THERAPY, GENE
  • Bursa Uludağ Üniversitesi Adresli: Evet

Özet

The identification of novel prognostic markers may help to better assess survival probability in different subgroups of patients with non-small-cell lung cancer (NSCLC) and to tailor treatment according to the molecular profile of the tumour.